Theriva Biologics Announces Pricing of $7.5 Million Public Offering - Stock Titan
2025-05-07 • Google News
Theriva Biologics Inc. (TOVX)
US$ 0.6432-20.59%
Price Chart
Key Statistics
Market Cap
$ 3.54M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
1.51M
52W High
$ 7.25
52W Low
$ 0.40
Dividend Yield
0.00%
Beta
0.83
Technicals
50-Day MA
0.8214
200-Day MA
1.4649
52 Week High
7.25
52 Week Low
0.4
About TOVX
Theriva Biologics, Inc., a clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States.
Employees
20
Headquarters
Rockville, MD
CEO
Mr. Steven A. Shallcross CPA
Latest News
Theriva Biologics Announces At-The-Market Stock Offering - TipRanks
2 days ago • Google News
Theriva Biologics (TOVX) to Present Key Retinoblastoma Trial Data | TOVX Stock News - GuruFocus
4 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg